TELEREHAPP-supported pulmonary rehabilitation: Pulmonary rehabilitation supported by TELEREHAPP consisted of a program delivered in private physiotherapy practice using a digital health application designed to support the implementation, monitoring, and follow-up of rehabilitation and physical activity programs. Depending on the physiotherapist's usual practice and the patient's needs, the program could include endurance exercise training, muscle strengthening, physical activity coaching, self-administered questionnaires, and individualized monitoring by the physiotherapist. The digital solution was used as a support tool for care delivery and follow-up; the content, duration, frequency, and modalities of the program were determined by the treating physiotherapist.
Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and financial barriers. Delivering pulmonary rehabilitation in private physiotherapy practices may improve access to care, but implementation can be challenged by limited resources, equipment, and support tools.
A field-based implementation program was conducted from summer 2025 to support physiotherapists in delivering pulmonary rehabilitation in private practice through the provision of a digital support solution (TELEREHAPP) and, where appropriate, associated equipment. During this program, physiotherapists collected data on solution use, patient characteristics, and available clinical follow-up indicators. Satisfaction and perceived usability were assessed among both physiotherapists and patients.
This retrospective study aims to analyze the data already collected during the implementation program to evaluate the feasibility of implementation, use, and acceptability of the TELEREHAPP digital solution in private physiotherapy practice, and to describe changes in available clinical outcomes among participating patients.
| Facility | City | Region | Status |
|---|---|---|---|
| ADIR Association | Rouen | France |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07687836 on ClinicalTrials.gov ↗ ← All trials in France